Category: M&A, Partnerships
Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy
Roche obtains the exclusive right to launch and commercialize SRP-9001, Sarepta’s investigational micro-dystrophin gene therapy for Duchenne muscular dystrophy (DMD) outside the United States At closing, Roche will pay an upfront of $750million in cash and $400million worth in equity Sarepta is eligible to receive up to $1.7billion in regulatory and sales milestones, plus royalties... Read more
GE Healthcare Life Sciences and UMass Medical School Establish Large Scale Viral Vector Manufacturing Facility
New facility will help alleviate bottlenecks in manufacturing that impact preclinical research December 16, 2019 – GE Healthcare (GEHC) Life Sciences and the University of Massachusetts Medical School (UMMS) have come together to establish a Large Scale Viral Vector Manufacturing Facility. The new facility will provide large quantities of high-quality recombinant adeno-associated virus (AAV) vectors... Read more
PerkinElmer Announces Collaboration with Emerald Scientific for Cannabis and Hemp Analytical Solutions & Services
Both Companies to Exhibit at MJBizCon in Las Vegas this Week WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced a collaboration with Emerald Scientific, a leading cannabis and hemp lab technology provider and industry thought leader. With this agreement, Emerald Scientific will offer PerkinElmer’s cannabis and hemp testing portfolio... Read more
American-Made, Eco-Friendly Adventure Brands–Nalgene Outdoor and Corbeaux Clothing–Partner to Support Domestic Drinking Water Initiatives
American-Made, Eco-Friendly Adventure Brands–Nalgene Outdoor and Corbeaux Clothing–Partner to Support Domestic Drinking Water Initiatives Cobranded Limited-Edition Apparel and Reusable Water Bottles to Raise Funds for Nalgene Water Fund ROCHESTER, N.Y., Dec. 4, 2019 /PRNewswire/ — American-made, eco-friendly adventure brands Nalgene Outdoor, maker of reusable water bottles, and Corbeaux Clothing, stylish, eco-conscious adventure apparel, announce a partnership... Read more
Affidea and GE Healthcare sign a $100 million technology partnership agreement for innovative imaging fleet, digital workflow solutions and contrast media
Buc, France – December 2, 2019 – GE Healthcare and Affidea, the pan-European leader in advanced diagnostic imaging, outpatient and cancer care services, have signed a multi-year agreement to deploy imaging and digital technologies across the Affidea network. GE Healthcare will install 200+ new equipment in Affidea’s network of centers across Europe. The deal includes the... Read more
GE Healthcare Invests in Future of Healthcare with 3D Printing, Robotic Surgery and Virtual Patient Monitoring Collaborations
Chicago, US – December 1, 2019 – GE Healthcare today announced its investments in and collaborations with Formlabs, CMR Surgical Ltd. and Decisio Health, companies specializing in 3D printing, surgical robotics and virtual care monitoring respectively. When paired with GE Healthcare’s diagnostic expertise and global scale, these three novel healthcare technologies will help expand clinical... Read more
Xylem and Manchester City Football Group Partner in “Cityzens Giving” For Second Annual Safe Water Project
RYE BROOK, N.Y.–(BUSINESS WIRE)–Nov. 13, 2019– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, is partnering with the Cityzens Giving annual charitable campaign launched today, a Manchester City Football Club global community initiative, which helps young leaders around the world change lives through the... Read more
Abcam agrees to acquire Expedeon’s Proteomics and Immunology business, expanding offerings into the fast-growing conjugation segment
Acquisition of leading protein conjugation technologies and products with wellknown industry brands, including Lightning-Link® and CaptSureTM Complementary to Abcam’s existing antibody and multiplex growth strategy, with high customer overlap Acquisition expected to be accretive from the first full year of ownership (FY21)1 and to deliver a ROIC (pretax) ahead of the Group’s WACC by the... Read more
Abcam and BrickBio Announce a Partnership to Incorporate Conjugation-Ready Sites into Recombinant Antibodies Across Abcam’s Portfolio
BrickBio’s technology enables efficient placement of unnatural amino acids into recombinant antibodies at specific sites Together, the organizations will industrialize the technology to serve both the research and diagnostic markets CAMBRIDGE, UK and BOSTON, MA, USA, November 08, 2019 / B3C newswire / — Abcam plc, a global innovator in life science reagents and tools, is today pleased... Read more